Evidence map›Paper›PMID 40702924›Full record

ArticleBritish journal of clinical pharmacology2025

Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: Insights from multi-metric evaluation.

Gabriela Rolová, Svetlana Skurtveit, Marte Handal, Geana Paula Kurita, Torgeir Gilje Lid, Ingvild Odsbu, Mikael Hoffmann

Abstract read
In one paragraph

Article in British journal of clinical pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriela RolováFirst Faculty of Medicine, Department of Addictology, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-7238-7449
Svetlana SkurtveitUniversity of Oslo, Norwegian Centre for Addiction Research, Oslo, Norway.
Marte HandalUniversity of Oslo, Norwegian Centre for Addiction Research, Oslo, Norway.
Geana Paula KuritaDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Torgeir Gilje LidCentre for Alcohol and Drug Research (KORFOR), Stavanger University Hospital, Stavanger, Norway.ORCID https://orcid.org/0000-0003-0088-411X
Ingvild OdsbuUniversity of Oslo, Norwegian Centre for Addiction Research, Oslo, Norway.
Mikael HoffmannDepartment of Health, Medicine and Caring Sciences, Linköping University, Sweden.

Funding

Charles University institutional support program Cooperatio (research area HEAS)Johannes Amos Comenius Programme (OP JAK) - MSCA Fellowship CZ - UK3 CZ.02.01.01/00/22_010/0008820Norwegian Research Council 320360
6 · The paper itself

Abstract

aimsMonitoring opioid prescribing across different healthcare systems is essential to understanding population-level exposure and informing global health policies. This study examined opioid utilization in Scandinavian countries between 2010 and 2023 using multiple complementary metrics, addressing the limitations of single-metric comparisons.

methodsA repeated cross-sectional study utilizing publicly available drug use statistics on opioid analgesics (ATC group N02A) dispensed in pharmacies from Denmark, Norway and Sweden. We assessed annual changes in utilization based on four metrics: 1-year prevalence (users/1000 inhabitants/year), defined daily doses (DDD)/1000 inhabitants/day (TID), morphine milligram equivalents (MMEs)/TID, and MMEs/user/year.

resultsOpioid use declined in Denmark and Sweden-in both 1-year user prevalence and volumes of MMEs-while stabilizing in Norway. Norway consistently had a higher and stable prevalence of opioid users. Denmark led in total amounts of MMEs dispensed, likely due to more frequent morphine and oxycodone use, whereas Norway ranked highest in DDDs. Denmark and Sweden showed increasing preference for "strong opioids", while codeine-paracetamol and tramadol remained predominant in Norway. The prevalence of oxycodone users increased in Norway and Sweden, with Sweden having the highest prevalence of users but the lowest annual average volumes per user.

conclusionsThis study found major differences in total opioid use and substance-specific prescribing patterns, reflecting diverse pain management strategies across Scandinavia. Changing use patterns suggest evolving prescribing strategies and possible shifts in the target group for opioid pain therapy. In addition, metric-dependent variation underscores the need for using multiple complementary metrics to accurately interpret opioid utilization trends.

Indexed as

Analgesics, OpioidDrug PrescriptionsDrug UtilizationPractice Patterns, Physicians'Cross-Sectional StudiesHumansNorwayPrevalenceScandinavian and Nordic CountriesAnalgesics, Opioidanalgesiamorphine milligram equivalents (MMEs)opioidspainpharmacoepidemiologyprescribingScandinavia

Identifiers

PMID40702924
PMCPMC12648362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.